Profile Detail
ADU-CRI Research teams comprise of national and International Scientists and Clinicians that have expertise in cancer care and research.
ADU-CRI Research teams comprise of national and International Scientists and Clinicians that have expertise in cancer care and research.
Dr. Sameer Mirza’s work focuses on Transcriptional Alteration/Deficiency in Activation (TADA/ADA)3, an estrogen receptor, coactivator part of SAGA and ATAC complex. He demonstrated its role in maintaining genomic instability, DNA repair process and histone acetylation and cancer. He also generated a Doxycycline induced mammary specific ECD transgenic mice model exhibiting breast cancer. Currently his lab is focusing on two major areas of research, therapy resistance and metastasis and underlying pathways in breast cancer. Dr. Mirza has published in high-impact journals, including Oncogene, Cancer Research, and Molecular Cancer therapeutics, Cancer Letters etc. He is also a recipient of several national and international grants.